EnteroMedics' Unattributed VC - II Round

EnteroMedics raised a round of funding on June 21, 2004. Investors include MPM Capital.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' Unattributed VC - II Round: